This is a snippet of the transcript, sign up to read more.
Constellation focuses on a great segment of the market which is niche businesses that are typically later stage. Because it's a full buyout without any further liquidity event for management, it self-selects the type of assets Constellation invest in. In our environment, there is a five-year exit horizon and, as a result, you can align the management's incentives to drive towards that exit.
This is a snippet of the transcript, sign up to read more.
I've wondered about that for many years. I was talking to an auditor, in 2012, who told me it couldn't go on forever. While interest rates have been low recently and people were doing stupid things, the pace of new company creation exceeded acquisitions. I don't have exact numbers to prove this but that's what I feel. The database of tracked software businesses was increasing every year up until the time I left. We weren't scrubbing the database clean but it was in the hundreds of thousands of companies. Maybe a third of those weren't a great fit, but the number was growing, not shrinking.
This is a snippet of the transcript, sign up to read more.
Things are getting more competitive, and there's a question whether other competitors will accept a five percentage point lower hurdle rate than Constellation. If that is acceptable, it becomes a race to the bottom. Constellation have a strong enough reputation and they have the capital, which attaches a premium to selling to them, but that only lasts so long. There could be a lowering of returns over time. Another risk is the quality of software businesses Constellation buys, which has declined on average since I was there. That doesn't show itself in the first few years; it shows up much later. These are businesses with antiquated legacy software with a handful of customers, which is like buying an annuity stream or a mine which gets mined dry over time. The risk there is their organic growth rates are not great. If that turns negative at some point, it will be a challenge to manage.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.